Downsizing Is A Routine Occurrence In Today's Competitive Marketplace

Downsizing is a recurring activity in corporate America. The American Management Association's 1994 survey on downsizing reports that, on average, two-thirds of the firms that cut jobs in a given calendar year will do so again the following year. In this survey, 72 percent of the responding companies downsized in at least one calendar year since January 1989; 46 percent in at least two years; 27 percent in three years or more. Clearly, American businesses now believe that periodic downsizing ha

Written byEdward Kostiner
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Downsizing is a recurring activity in corporate America. The American Management Association's 1994 survey on downsizing reports that, on average, two-thirds of the firms that cut jobs in a given calendar year will do so again the following year. In this survey, 72 percent of the responding companies downsized in at least one calendar year since January 1989; 46 percent in at least two years; 27 percent in three years or more. Clearly, American businesses now believe that periodic downsizing has become essential to staying competitive.

Personnel reductions will likely continue in industries employing chemical professionals. Recent activity has been primarily in the pharmaceutical industry, where there have been eight major acquisitions between November 1993 and January 1995. An article in the National Business Employment Weekly (Employment Briefs, March 5-March 11, 1995, page 27) noted that the pharmaceutical industry ranks fourth in numbers of employees separated, behind retailing, financial services, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies